FILING ANALYSIS · WEDNESDAY, OCTOBER 21
Medpace Holdings, Inc. MEDP — 8-K: Results of Operations and Financial Condition
positive
Medpace reported a strong third quarter with revenue increasing 8.5% year-over-year to $716.0 million and GAAP net income rising to $137.5 million, or $4.84 per diluted share, also the company announced a new $1.0 billion stock repurchase authorization, effective October 20, 2026, which replaces the previous authorization that had $527.0 million remaining
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →